227 related articles for article (PubMed ID: 12667305)
1. Targeting bcl-2 by triplex-forming oligonucleotide--a promising carrier for gene-radiotherapy.
Shen C; Rattat D; Buck A; Mehrke G; Polat B; Ribbert H; Schirrmeister H; Mahren B; Matuschek C; Reske SN
Cancer Biother Radiopharm; 2003 Feb; 18(1):17-26. PubMed ID: 12667305
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells.
Napoli S; Negri U; Arcamone F; Capobianco ML; Carbone GM; Catapano CV
Nucleic Acids Res; 2006; 34(2):734-44. PubMed ID: 16449206
[TBL] [Abstract][Full Text] [Related]
3. Antiparallel polypurine phosphorothioate oligonucleotides form stable triplexes with the rat alpha1(I) collagen gene promoter and inhibit transcription in cultured rat fibroblasts.
Joseph J; Kandala JC; Veerapanane D; Weber KT; Guntaka RV
Nucleic Acids Res; 1997 Jun; 25(11):2182-8. PubMed ID: 9153319
[TBL] [Abstract][Full Text] [Related]
4. An efficient antigene activity and antiproliferative effect by targeting the Bcl-2 or survivin gene with triplex forming oligonucleotides containing a W-shaped nucleoside analogue (WNA-βT).
Taniguchi Y; Sasaki S
Org Biomol Chem; 2012 Oct; 10(41):8336-41. PubMed ID: 22987068
[TBL] [Abstract][Full Text] [Related]
5. A novel triplex-forming oligonucleotide targeted to human cyclin D1 (bcl-1, proto-oncogene) promoter inhibits transcription in HeLa cells.
Kim HG; Miller DM
Biochemistry; 1998 Feb; 37(8):2666-72. PubMed ID: 9485417
[TBL] [Abstract][Full Text] [Related]
6. (A,G)-oligonucleotides form extraordinary stable triple helices with a critical R.Y sequence of the murine c-Ki-ras promoter and inhibit transcription in transfected NIH 3T3 cells.
Alunni-Fabbroni M; Pirulli D; Manzini G; Xodo LE
Biochemistry; 1996 Dec; 35(50):16361-9. PubMed ID: 8973212
[TBL] [Abstract][Full Text] [Related]
7. Triplex forming oligonucleotide targeted to 3'UTR downregulates the expression of the bcl-2 proto-oncogene in HeLa cells.
Shen C; Buck A; Mehrke G; Polat B; Gross H; Bachem M; Reske S
Nucleic Acids Res; 2001 Feb; 29(3):622-8. PubMed ID: 11160882
[TBL] [Abstract][Full Text] [Related]
8. Intercalator conjugates of pyrimidine locked nucleic acid-modified triplex-forming oligonucleotides: improving DNA binding properties and reaching cellular activities.
Brunet E; Corgnali M; Perrouault L; Roig V; Asseline U; Sørensen MD; Babu BR; Wengel J; Giovannangeli C
Nucleic Acids Res; 2005; 33(13):4223-34. PubMed ID: 16049028
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of in vitro transcription by a triplex-forming oligonucleotide targeted to human c-myc P2 promoter.
Kim HG; Miller DM
Biochemistry; 1995 Jun; 34(25):8165-71. PubMed ID: 7794930
[TBL] [Abstract][Full Text] [Related]
10. DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene.
Carbone GM; McGuffie E; Napoli S; Flanagan CE; Dembech C; Negri U; Arcamone F; Capobianco ML; Catapano CV
Nucleic Acids Res; 2004; 32(8):2396-410. PubMed ID: 15121897
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of T7 RNA polymerase transcription by phosphate and phosphorothioate triplex-forming oligonucleotides targeted to a R.Y site downstream from the promoter.
Alunni-Fabbroni M; Manfioletti G; Manzini G; Xodo LE
Eur J Biochem; 1994 Dec; 226(3):831-9. PubMed ID: 7813472
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of transcription of the human c-myc protooncogene by intermolecular triplex.
Kim HG; Reddoch JF; Mayfield C; Ebbinghaus S; Vigneswaran N; Thomas S; Jones DE; Miller DM
Biochemistry; 1998 Feb; 37(8):2299-304. PubMed ID: 9485376
[TBL] [Abstract][Full Text] [Related]
13. Targeting of an interrupted polypurine:polypyrimidine sequence in mammalian cells by a triplex-forming oligonucleotide containing a novel base analogue.
Semenyuk A; Darian E; Liu J; Majumdar A; Cuenoud B; Miller PS; Mackerell AD; Seidman MM
Biochemistry; 2010 Sep; 49(36):7867-78. PubMed ID: 20701359
[TBL] [Abstract][Full Text] [Related]
14. Triplex formation inhibits HER-2/neu transcription in vitro.
Ebbinghaus SW; Gee JE; Rodu B; Mayfield CA; Sanders G; Miller DM
J Clin Invest; 1993 Nov; 92(5):2433-9. PubMed ID: 7901237
[TBL] [Abstract][Full Text] [Related]
15. Binding of triple helix forming oligonucleotides to sites in gene promoters.
Durland RH; Kessler DJ; Gunnell S; Duvic M; Pettitt BM; Hogan ME
Biochemistry; 1991 Sep; 30(38):9246-55. PubMed ID: 1892832
[TBL] [Abstract][Full Text] [Related]
16. Purine twisted-intercalating nucleic acids: a new class of anti-gene molecules resistant to potassium-induced aggregation.
Paramasivam M; Cogoi S; Filichev VV; Bomholt N; Pedersen EB; Xodo LE
Nucleic Acids Res; 2008 Jun; 36(10):3494-507. PubMed ID: 18456705
[TBL] [Abstract][Full Text] [Related]
17. Purine- and pyrimidine-triple-helix-forming oligonucleotides recognize qualitatively different target sites at the ribosomal DNA locus.
Maldonado R; Filarsky M; Grummt I; Längst G
RNA; 2018 Mar; 24(3):371-380. PubMed ID: 29222118
[TBL] [Abstract][Full Text] [Related]
18. Improved synthesis of daunomycin conjugates with triplex-forming oligonucleotides. The polypurine tract of HIV-1 as a target.
Capobianco ML; De Champdoré M; Arcamone F; Garbesi A; Guianvarc'h D; B Arimondo P
Bioorg Med Chem; 2005 May; 13(9):3209-18. PubMed ID: 15809156
[TBL] [Abstract][Full Text] [Related]
19. Improved bioactivity of G-rich triplex-forming oligonucleotides containing modified guanine bases.
Rogers FA; Lloyd JA; Tiwari MK
Artif DNA PNA XNA; 2014; 5(1):e27792. PubMed ID: 25483840
[TBL] [Abstract][Full Text] [Related]
20. Antigene-block strategy: effective regulation of gene expression by 2',4'-BNA-modified TFOs with an additional stem-loop structure.
Tsuda N; Matsumoto A; Ito A; Uneda T; Tanabe A; Obika S; Imanishi T
Nucleic Acids Symp Ser (Oxf); 2005; (49):335-6. PubMed ID: 17150770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
